Medtox Scientific 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2012
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Registrant’s telephone number, including area code: (651) 636-7466
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 2.02. Results of Operations and Financial Condition
On February 9, 2012, MEDTOX Scientific, Inc. announced results for the fourth quarter and year-ended December 31, 2011, as described in the press release attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
The following exhibit is filed as part of this report:
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: February 9, 2012 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer
INDEX TO EXHIBITS